{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Naloxegol: A Review of Clinical Trials and Applications to Practice
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
This article has been approved by the Orthopaedic Nurses Certification Board for Category B credit toward recertification as an ONC.Purpose of Activity
To provide information on the use of naloxegol to treat opioid-induced constipation (OIC).Learning Objectives
After completing this continuing education activity you will be able to:
- Examine the treatment of OIC with a focus on the pharmacokinetics of naloxegol.
- Select the dose, administration, and adverse effects of naloxegol.
Disclosures
The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$10.00
Credits:
- ANCC 1.0 CH / 1.0 APH
- DC - BON 1.0 CH
- KY-BON 1.0 CH
- GA - BON 1.0 CH
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.
Awarded Advanced Pharmacology Hours
Awarded Advanced Pharmacology Hours
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: ON0519D
Published: May/Jun 2019
Expires: 12/31/2026
Sources:
Orthopaedic Nursing
Required Passing Score: 12/16 (75%)
Specialties:
Gastroenterology